Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Validation of a Cell-Free DNA NGS Assay for Hematological Malignancies

Erika Gedvilaite, Sara DiNapoli, Coleman Spence, Monica S. Diosdado, Anna Razumova, Anita S. Bowman, Dana WY Tsui, Gilles Salles, Connie Lee Batlevi, Gottfried von Keudell, Ryan Ptashkin, Ahmet Zehir, Ryma Benayed, Michael F. Berger, A. Rose Brannon, Maria E. Arcila

Blood (2022) 140 (Supplement 1): 6430–6431.

https://doi.org/10.1182/blood-2022-167461

Published: 2022

Journal Articles

Molecular Profiling across Lymphoma Subtypes Using MSK-Impact Next Generation Sequencing

Blood (2022) 140 (Supplement 1): 9251–9253.

https://doi.org/10.1182/blood-2022-158783

Published: 2022

Journal Articles

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Blood (2021) 137 (15): 2103–2113.

https://doi.org/10.1182/blood.2020007488

Published: 2021

Includes: Supplemental data

Journal Articles

Interplay between Chromosomal Alterations and Gene Mutations Shapes the Evolutionary Trajectory of Clonal Hematopoiesis

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141882

Published: 2020

Journal Articles

Germline Contributions to Clonal Hematopoiesis in Solid Cancer Patients

Sebastià Franch-Expósito, PhD, Preethi Srinivasan, PhD, Ryan Ptashkin, MS, Chaitanya Bandlamudi, PhD, Kelly L. Bolton, MD PhD, Erika Gedvilaite, Kamal Menghrajani, MD, Diana Mandelker, MD PhD, Elizabeth Comen, MD, Larry Norton, MD, Ryma Benayed, PhD, Teng Gao, Elli Papaemmanuil, PhD, Barry S Taylor, PhD, Ross L. Levine, MD, Michael F. Berger, PhD, Ahmet Zehir, PhD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-140868

Published: 2020

Journal Articles

Creating a Variant Database for the American Society of Hematalogy By Consensus Variant Classification of Common Genes Associated with Hematologic Malignancies

Niroshan Nadarajah, Alex Wagner, PhD, Rafael Bejar, MD PhD, Mark Ewalt, MD, Annette S. Kim, MD, Michelle M. Le Beau, PhD, Xiaotu Ma, PhD, Manja Meggendorfer, PhD, Jamile M. Shammo, MD, Gabriella Ryan, Alexa J. Siddon, MD, David P. Steensma, MD, Matthew J. Walter, MD, Ahmet Zehir, PhD, Jinghui Zhang, PhD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-141204

Published: 2020

Journal Articles

Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients

Kelly L. Bolton, MD PhD, Michael Foote, MD, Justin Jee, Anton Safonov, MD, Ryan Ptashkin, MS, Sean Devlin, PhD, Erika Gedvilaite, Teng Gao, Elli Papaemmanuil, PhD, Melissa S. Pessin, MD PhD, Mini Kamboj, Joseph Vijai, PhD, Kenneth Offit, MD, Phillip Awadalla, PhD, Pradeep Nataranjan, Michael F. Berger, PhD, Larry Norton, MD, Ross L. Levine, MD, Ahmet Zehir, PhD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-143041

Published: 2020

Journal Articles

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Andrew Dunbar, MD, Kelly Bolton, MD PhD, Sean M. Devlin, PhD, Francisco Sanchez-Vega, PhD, Jianjiong Gao, PhD, Jodi V. Mones, MD, Jonathan M. Wills, BA, Daniel Kelly, MS, Mirko Farina, MD, Sirish Kishore, MD, Krishna Juluru, MD, Neil Iyengar, MD, David M. Hyman, MD, Ahmet Zehir, PhD, Wungki Park, MD, Alok A Khorana, MD, Gerald A. Soff, MD, Simon Mantha, MDMPH

Blood (2019) 134 (Supplement_1): 633.

https://doi.org/10.1182/blood-2019-124242

Published: 2019

Journal Articles

Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies

Linde A Miles, PhD, Robert L Bowman, PhD, Tiffany R Merlinsky, Aik Ooi, PhD, Pedro Mendez, Christopher Famulare, MS, Minal A Patel, MPH, Kelly Bolton, MD PhD, Neil Palmisiano, MD MS, Martin P. Carroll, MD, Elli Papaemmanuil, PhD, Ahmet Zehir, PhD, Sara E. Meyer, PhD, Aaron D Viny, MDMS, Ross L. Levine, MD

Blood (2019) 134 (Supplement_1): 913.

https://doi.org/10.1182/blood-2019-128763

Published: 2019

Journal Articles

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

Blood (2019) 134 (Supplement_1): 2148.

https://doi.org/10.1182/blood-2019-125068

Published: 2019

Journal Articles

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Blood (2018) 132 (Supplement 1): 747.

https://doi.org/10.1182/blood-2018-99-119530

Published: 2018

Journal Articles

Use of Next Generation Sequencing and Single Nucleotide Polymorphism (SNP) Fingerprinting to Assess Post Transplant Engraftment Status

Abhinita S. Mohanty, MS, Juan Camilo Gomez-Gelvez, MD, Kseniya Petrova-Drus, Michael Zaidinski, Wei Wang, Jin Juan Yao, MD PhD, Caleb Ho, MD, Ahmet Zehir, PhD, Maria E. Arcila

Blood (2017) 130 (Supplement 1): 1943.

https://doi.org/10.1182/blood.V130.Suppl_1.1943.1943

Published: 2017

Journal Articles

Population-Scale Identification of Clonal Hematopoiesis Derived Mutations in Solid Tumor Mutation Profiling

Ryan Ptashkin, MS, Catherine C. Coombs, MD, David M. Hyman, MD, David Solit, MD, Jose Baselga, MD, Maria E. Arcila, Marc Ladanyi, MD, Ross L. Levine, MD, Michael F. Berger, PhD, Ahmet Zehir, PhD

Blood (2017) 130 (Supplement 1): 2418.

https://doi.org/10.1182/blood.V130.Suppl_1.2418.2418

Published: 2017

Journal Articles

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Catherine C. Coombs, MD, Ahmet Zehir, PhD, Sean Devlin, PhD, Ashwin Kishtagari, MD, David M. Hyman, David Solit, MD, Mark Robson, MD, Jose Baselga, MD PhD, Maria Arcila, MD, Martin S. Tallman, MD, Ross L. Levine, MD, Michael Berger, PhD

Blood (2016) 128 (22): 37.

https://doi.org/10.1182/blood.V128.22.37.37

Published: 2016

Journal Articles

Next-Generation Sequencing of Matched Normal Blood Identifies Clonal Hematopoiesis in a Significant Subset of Solid Tumor Patients without Hematologic Malignancies

Catherine C. Coombs, MD, Ahmet Zehir, PhD, Sean Devlin, PhD, Sumit Middha, PhD, Donavan Cheng, PhD, Ashwin Kishtagari, MD, David M. Hyman, David Solit, MD, Mark Robson, MD, Jose Baselga, MD PhD, Maria Arcila, MD, Mark Ladanyi, MD, Martin S Tallman, MD, Ross L. Levine, MD, Michael Berger, PhD

Blood (2015) 126 (23): 2447.

https://doi.org/10.1182/blood.V126.23.2447.2447

Published: 2015

Journal Articles

Telomere Length Plays No Role in Clinical Unit Dominance After Double-Unit Cord Blood Transplantation

Beth Ashbridge, Ahmet Zehir, Lingbo Shen, Juliet N Barker, MBBS, (Hons), FRACP, Malcolm A.S. AS Moore

Blood (2012) 120 (21): 4661.

https://doi.org/10.1182/blood.V120.21.4661.4661

Published: 2012

NARROW

Validation of a Cell-Free DNA NGS Assay for Hematological Malignancies

Molecular Profiling across Lymphoma Subtypes Using MSK-Impact Next Generation Sequencing

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors

Interplay between Chromosomal Alterations and Gene Mutations Shapes the Evolutionary Trajectory of Clonal Hematopoiesis

Germline Contributions to Clonal Hematopoiesis in Solid Cancer Patients

Creating a Variant Database for the American Society of Hematalogy By Consensus Variant Classification of Common Genes Associated with Hematologic Malignancies

Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients

Extended Mutational Profiling By MSK-IMPACT TM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy

Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies

Annotation of Somatic Genomic Variants in Hematologic Diseases Using OncoKB, a Precision Oncology Knowledgebase

Oncologic Therapy for Solid Tumors Alters the Risk of Clonal Hematopoiesis

Use of Next Generation Sequencing and Single Nucleotide Polymorphism (SNP) Fingerprinting to Assess Post Transplant Engraftment Status

Population-Scale Identification of Clonal Hematopoiesis Derived Mutations in Solid Tumor Mutation Profiling

Mutational Analysis of Clonal Hematopoiesis in Solid Tumor Patients Illustrates the Critical Role of Systemic Anti-Cancer Therapies in the Evolution of Somatic Leukemia Disease Alleles

Next-Generation Sequencing of Matched Normal Blood Identifies Clonal Hematopoiesis in a Significant Subset of Solid Tumor Patients without Hematologic Malignancies

Telomere Length Plays No Role in Clinical Unit Dominance After Double-Unit Cord Blood Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only